Showing results (251-260 of 262) with videos related to
Sort By:
Pageof 27
American Journal of Hematology|December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patientsSylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.Clinical Lymphoma, Myeloma & Leukemia|December 13, 2021
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) GroupMauricette Michallet, Mohamad Sobh, Stephane Morisset, et al.Blood|August 19, 2021
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapyRaphael Itzykson, Elise Fournier, Céline Berthon, et al.Blood|November 3, 2007
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsLionel Adès, Miguel A Sanz, Sylvie Chevret, et al.Blood|March 7, 2024
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemiaYves Chalandon, Philippe Rousselot, Sylvie Chevret, et al.Blood Advances|February 1, 2023
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AMLStéphane de Botton, Pierre Fenaux, Karen Yee, et al.Blood|April 29, 2016
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALLPhilippe Rousselot, Marie Magdelaine Coudé, Nicola Gokbuget, et al.Blood|September 2, 2020
A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemiaLaurène Fenwarth, Xavier Thomas, Stéphane de Botton, et al.Haematologica|March 9, 2023
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 studyCorentin Orvain, Sylvain Chantepie, Xavier Thomas, et al.Blood|July 12, 2015
Disease evolution and outcomes in familial AML with germline CEBPA mutationsKiran Tawana, Jun Wang, Aline Renneville, et al.Pageof 27